These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 19549106

  • 1. Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase.
    Voyron S, Rocco F, Ceruti M, Forni P, Pla AF, Sarpietro MG, Varese GC, Marchisio VF.
    Mycoses; 2010 Nov; 53(6):481-7. PubMed ID: 19549106
    [Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of fungi to acyclic inhibitors of 2,3-oxidosqualene cyclases.
    Airaudi D, Ceruti M, Bianco C, Filipello Marchisio V.
    Mycoses; 1996 Nov; 39(1-2):51-6. PubMed ID: 8786759
    [Abstract] [Full Text] [Related]

  • 3. In vitro antifungal and antibacterial activities of pentacycloundecane tetra-amines.
    Onajole OK, Coovadia Y, Govender T, Kruger HG, Maguire GE, Naidu D, Singh N, Govender P.
    Chem Biol Drug Des; 2011 Apr; 77(4):295-9. PubMed ID: 21241455
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
    Sanguinetti M, Posteraro B, Romano L, Battaglia F, Lopizzo T, De Carolis E, Fadda G.
    J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
    [Abstract] [Full Text] [Related]

  • 5. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ, Giusiano G, Cárdenes D, Hernández-Molina JM, Eraso E, Quindós G, Guardia C, del Valle O, Tur-Tur C, Guarro J.
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes.
    Castro C, Serrano MC, Valverde A, Pemán J, Almeida C, Martín-Mazuelos E.
    Chemotherapy; 2008 Jun; 54(6):427-30. PubMed ID: 18824849
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
    Chadeganipour M, Nilipour S, Havaei A.
    Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
    [Abstract] [Full Text] [Related]

  • 10. [An update on antifungal susceptibility testing].
    Tapia P CV.
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [Abstract] [Full Text] [Related]

  • 11. In vitro antifungal activity of heterocyclic organoboron compounds against Trichophyton mentagrophytes and Microsporum canis obtained from clinical isolates.
    Pir M, Budak F, Metiner K.
    Braz J Microbiol; 2022 Sep; 53(3):1297-1303. PubMed ID: 35697970
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes.
    Ghannoum MA, Welshenbaugh A, Imamura Y, Isham N, Mallefet P, Yamaguchi H.
    Mycoses; 2010 Jul; 53(4):311-3. PubMed ID: 19422522
    [Abstract] [Full Text] [Related]

  • 13. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY, Wan Z, Wang AP, Shen YN, Lu CM, Li M, Xi LY, Liu WD, Zeng FQ.
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA, Wraith LA, Cai B, Nyirady J, Isham N.
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [Abstract] [Full Text] [Related]

  • 15. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
    Ceruti M, Rocco F, Viola F, Balliano G, Milla P, Arpicco S, Cattel L.
    J Med Chem; 1998 Feb 12; 41(4):540-54. PubMed ID: 9484504
    [Abstract] [Full Text] [Related]

  • 16. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors.
    Buckner FS, Griffin JH, Wilson AJ, Van Voorhis WC.
    Antimicrob Agents Chemother; 2001 Apr 12; 45(4):1210-5. PubMed ID: 11257036
    [Abstract] [Full Text] [Related]

  • 17. Antifungal activities of the essential oils in Syzygium aromaticum (L.) Merr. Et Perry and Leptospermum petersonii Bailey and their constituents against various dermatophytes.
    Park MJ, Gwak KS, Yang I, Choi WS, Jo HJ, Chang JW, Jeung EB, Choi IG.
    J Microbiol; 2007 Oct 12; 45(5):460-5. PubMed ID: 17978807
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of Phytolacca dodecandra (Endod) against dermatophytes.
    Woldeamanuel Y, Abate G, Chryssanthou E.
    Ethiop Med J; 2005 Jan 12; 43(1):31-4. PubMed ID: 16370528
    [Abstract] [Full Text] [Related]

  • 19. Trends in antifungal susceptibility testing using CLSI reference and commercial methods.
    Cantón E, Espinel-Ingroff A, Pemán J.
    Expert Rev Anti Infect Ther; 2009 Feb 12; 7(1):107-19. PubMed ID: 19622060
    [Abstract] [Full Text] [Related]

  • 20. In vitro antifungal activity of dragon's blood from Croton urucurana against dermatophytes.
    Gurgel LA, Sidrim JJ, Martins DT, Cechinel Filho V, Rao VS.
    J Ethnopharmacol; 2005 Feb 28; 97(2):409-12. PubMed ID: 15707783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.